Xiaomin Yang
National Health Committee Key Laboratory Of Pediatric Hematology And Oncology
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Long-term outcomes of co-administration of CD19 and CD22 CAR-T cell therapy in pediatric patients with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.
Journal: Frontiers in medicine
Published: February 22, 2026
Impact of corticosteroids on the efficacy of CD19/22 CAR-T cell therapy in pediatric patients with B-ALL: a single-center study.
Journal: Frontiers in pediatrics
Published: August 23, 2024
Intelligent and precise auxiliary diagnosis of breast tumors using deep learning and radiomics.
Journal: PloS one
Published: August 08, 2024
A 16-Year-Old Girl with Sinonasal Cutaneous Fistula Following Excision and Radiotherapy for Rhabdomyosarcoma Requiring Reconstructive Surgery Using an Expanded Forehead Flap.
Journal: The American journal of case reports
Published: May 13, 2024
Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma.
Journal: Frontiers in immunology
Published: May 09, 2023
Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy.
Journal: Journal of translational medicine
Published: December 08, 2022
Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 08, 2022
Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary Relapse.
Journal: Cancer research and treatment
Published: March 29, 2021
Successful Treatment of TCF3-HLF-positive Childhood B-ALL with Chimeric Antigen Receptor T-Cell Therapy.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 10, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026